These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 1511023)
1. Osteosarcoma and other cancers of bone. Picci P Curr Opin Oncol; 1992 Aug; 4(4):674-80. PubMed ID: 1511023 [TBL] [Abstract][Full Text] [Related]
2. Canine osteosarcoma: amputation and chemoimmunotherapy. MacEwen EG; Kurzman ID Vet Clin North Am Small Anim Pract; 1996 Jan; 26(1):123-33. PubMed ID: 8825571 [TBL] [Abstract][Full Text] [Related]
3. Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide. Kleinerman ES Hematol Oncol Clin North Am; 1995 Aug; 9(4):927-38. PubMed ID: 7490249 [TBL] [Abstract][Full Text] [Related]
4. Liposome-encapsulated muramyl tripeptide: a new biologic response modifier for the treatment of osteosarcoma. Kleinerman ES; Maeda M; Jaffe N Cancer Treat Res; 1993; 62():101-7. PubMed ID: 8096724 [TBL] [Abstract][Full Text] [Related]
5. Osteosarcoma and other tumors of bone. Mertens WC; Bramwell V Curr Opin Oncol; 1994 Jul; 6(4):384-90. PubMed ID: 7803539 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo enhancement of canine pulmonary alveolar macrophage cytotoxic activity against canine osteosarcoma cells. Kurzman ID; Shi F; Vail DM; MacEwen EG Cancer Biother Radiopharm; 1999 Apr; 14(2):121-8. PubMed ID: 10850295 [TBL] [Abstract][Full Text] [Related]
8. Prospectively planned analysis of data from a phase III study of liposomal muramyltripeptide phosphatidylethanolamine in the treatment of osteosarcoma. Romet-Lemonne JL; Mills B; Fridman WH; Munsell M J Clin Oncol; 2005 Sep; 23(26):6437-8. PubMed ID: 16155031 [No Abstract] [Full Text] [Related]
9. Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma. Meyers PA Expert Rev Anticancer Ther; 2009 Aug; 9(8):1035-49. PubMed ID: 19671023 [TBL] [Abstract][Full Text] [Related]
10. Osteosarcoma in the first decade of life. Nagarajan R; Weigel BJ; Thompson RC; Perentesis JP Med Pediatr Oncol; 2003 Nov; 41(5):480-3. PubMed ID: 14515397 [No Abstract] [Full Text] [Related]
11. Current concepts in the evaluation and treatment of osteosarcoma. Papagelopoulos PJ; Galanis EC; Vlastou C; Nikiforidis PA; Vlamis JA; Boscainos PJ; Fragiadakis EG; Stamos KG; Pantazopoulos T; Sim FH Orthopedics; 2000 Aug; 23(8):858-67; quiz 868-9. PubMed ID: 10952054 [No Abstract] [Full Text] [Related]
12. Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida studies. Graham-Pole J; Ayass M; Cassano W; Dickson N; Enneking W; Heare M; Heare T; Marcus R; Saleh R; Spanier S Cancer Treat Res; 1993; 62():339-46. PubMed ID: 8096749 [No Abstract] [Full Text] [Related]
13. Muramyl Tripeptide Plus Chemotherapy Reduces Metastasis in Non-Metastatic Osteosarcoma: A Single-Center Experience. Taçyıldız N; Unal E; Dinçaslan H; Çakmak HM; Köse K; Tanyıldız G; Kartal Ö Asian Pac J Cancer Prev; 2020 Mar; 21(3):715-720. PubMed ID: 32212798 [TBL] [Abstract][Full Text] [Related]
14. IIB osteosarcoma. Current management, local control, and survival statistics--The Netherlands. Veth RP Clin Orthop Relat Res; 1991 Sep; (270):67-71. PubMed ID: 1884561 [TBL] [Abstract][Full Text] [Related]